alexa Indomethacin Solid Dispersions: Pharmaceutical Development
ISSN : 2153-2435

Pharmaceutica Analytica Acta
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
March 07-09, 2016 Madrid, Spain

Estefania Tascon-Otero, Eva Navarro-Ruiz, Juan J Garcia-Rodriguez, Susana Torrado-Duran, Santiago Torrado-Duran, Covadonga Alvarez-Álvarez, Paloma M de la Torre-Iglesias
Complutense University of Madrid, Spain
Posters & Accepted Abstracts: Pharm Anal Acta
DOI: 10.4172/2153-2435.C1.028
Abstract
Indomethacin is a nonsteroidal anti-inflammatory drug which inhibits the cyclo-oxygenase enzyme, in order to reduce the precursors of prostaglandins and thromboxanes formation from arachidonic acid. Many therapeutical and side effects of indomethacin can be produced by the inhibition of prostaglandin synthesis in different tissues, while other actions may also contribute significantly to the therapeutic effect of indomethacin (Delta). It is used to reduce pain/swelling involved in osteoarthritis, rheumatoid arthritis, bursitis, tendinitis, gout, ankylosing spondylitis, and headaches. The drug is described as poorly soluble and highly permeable (Class II) drug. Because water-insoluble drugs often show low absorption and this undesirable physical property may increase the incidence of irritating side effects on the gastrointestinal tract because of a prolonged contact time with the mucosa. Our aim is to increase indomethacin solubility in order to reduce the gastrointestinal damage produced. In order to this, we have studied the solubility of indomethacin at three different pH (1.2; 7.4; 8.4). The best solubility was achieved at pH 8.4 adding sodium laurylsulfate (0,125 mg/mL). Six different formulations were prepared with different ratios of indomethacin and L-HPC (1:0; 1:1; 1:2.5; 1:5; 1:10; 1:20).
Biography

Estefanía Tascón (Pharm D) has obtained her degree in Pharmacy in 2014 at Salamanca University and she is attending her PhD, at Complutense University of Madrid. Our investigation group was formed at the Department of Pharmacy and Pharmaceutical Technology of the Complutense University of Madrid, and it has established collaboration with the Department of Parasitology. It is composed by several professors, from Parasitology and from Pharmaceutical Technology department, and several PhD students. We started studying indomethacin solid dispersions in 2015.

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords